Gore Medical — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Gore Medical, a division of W. L. Gore & Associates, is a well-established, privately-held leader in the medical device sector, specializing in cardiovascular and surgical implants. Its core strength lies in its deep expertise with expanded polytetrafluoroethylene (ePTFE) and related biomaterials, which form the foundation for a diverse portfolio of commercial products including vascular grafts, endoprostheses, and occluders. The company is in a mature commercial stage, generating significant revenue through direct sales, and maintains a strong focus on clinical evidence and physician education to support its marketed technologies.

CardiovascularSurgical

Technology Platform

Proprietary material science platform based on expanded polytetrafluoroethylene (ePTFE) and related biomaterials, engineered for specific mechanical, biocompatibility, and bioactive properties for use in implants, grafts, and reinforcements.

Opportunities

The global shift towards minimally invasive surgical and endovascular procedures creates sustained demand for Gore's specialized grafts and implants.

Aging populations worldwide are increasing the prevalence of cardiovascular and soft tissue repair conditions, expanding the addressable patient population.

There is significant opportunity to grow market share in emerging economies where access to advanced medical technology is increasing.

Risk Factors

Intense competition from large, diversified medtech companies and agile startups could erode market share and exert pricing pressure.

The company faces ongoing regulatory and reimbursement challenges across different global markets, which can delay launches and impact profitability.

Technological obsolescence is a constant threat if new materials or treatment paradigms surpass the capabilities of the core ePTFE platform.

Competitive Landscape

Gore Medical competes in the crowded cardiovascular and surgical mesh markets against giants like Medtronic, Boston Scientific, Abbott, and Terumo. Its primary competitive advantage is its deep, proprietary expertise in ePTFE biomaterials, which creates differentiated products with strong clinical histories. Competition is based on clinical data, physician relationships, product performance, pricing, and global commercial reach.

More companies in Drug Delivery & Formulation →More companies in United States →